AI In Life Science Analytics Market, By Offering (Software and Services), By Deployment Mode, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4658
|
Published Date
January 2026
|
Pages
310
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
AI in Life Science Analytics Market size was valued at US$ 2,105.3 Million in 2024, expanding at a CAGR of 11.45% from 2025 to 2032.
The AI in Life Science Analytics market focuses on using artificial intelligence technologies—such as machine learning, natural language processing (NLP), and generative AI—to process and interpret the massive, complex datasets generated across the life sciences. Pharmaceutical and biotechnology companies collect data from sources including genomics and other omics research, lab experiments, clinical trials, safety reports, scientific literature, electronic health records (EHRs), and insurance claims. Much of this data is fragmented, heterogeneous, or unstructured (e.g., physician notes and medical literature), making traditional analysis slow and difficult. AI helps by identifying patterns, predicting outcomes, and automating parts of the analysis that would otherwise be timeintensive for humans. As a result, AI is increasingly applied in drug discovery, clinical trial planning and patient recruitment, pharmacovigilance, realworld evidence studies, precision medicine, and in commercial functions like sales forecasting and supply chain analytics.
The importance of AI and analytics in life sciences is reflected in market adoption statistics: North America accounted for around 45%–49% of the global AI in life sciences analytics market share in 2024, driven by extensive AI deployments, cloud adoption, and partnerships across biopharma and research labs. Over half of life sciences enterprises now use predictive analytics to enhance operational efficiency, and more than 58% have implemented AIenabled platforms to support clinical development and precision healthcare strategies. These trends are supported by government and publicsector efforts worldwide to advance digital health and AI capabilities—for example, national AI policies and research funding initiatives in multiple countries aim to expand AI integration in healthcare and life sciences, reinforcing the longterm growth of this market segment.
AI In Life Science Analytics Market- Market Dynamics
Surging Government-Backed R&D Funding and Clinical Trial Growth Accelerate AI Adoption in Life Science Analytics
A key driver of the AI in Life Science Analytics market is the rising government investment in biomedical research combined with the rapid growth of clinical trials, which is generating vast amounts of complex data that require advanced analytics. Governments’ funding initiatives are fueling large-scale research programs, particularly in genomics, clinical studies, and biomedical research, creating a practical need for AI tools to efficiently process, analyze, and extract insights from these datasets. For instance, the U.S. National Institutes of Health (NIH) reported a budget authority of $47.5 billion in FY2023, which increased to $48.6 billion in FY2024, supporting extensive research programs that produce complex clinical and genomic datasets. Additionally, NIH obligations for AI-related research rose from approximately $1.5 billion in FY2018 to $2.3 billion in FY2022, highlighting the expansion of government-backed AI initiatives in life sciences. On the clinical research side, data from ClinicalTrials.g
AI In Life Science Analytics Market- Segmentation Analysis:
Clinical trials and cloud-based deployment are two key segments driving demand in the AI in Life Science Analytics market, as both are closely tied to rapidly growing data volumes and the need for scalable computing solutions. The expansion of clinical research activity has led to a surge in structured and unstructured trial data that requires cleaning, monitoring, and reporting. According to ClinicalTrials.gov (U.S. National Library of Medicine), registered studies surpassed 500,000 in 2024, up from the high-400,000s in 2023. This steady increase in trial records and associated documentation highlights the growing need for AI analytics in feasibility assessment, patient matching, protocol monitoring, and faster insight generation.
Drug-safety monitoring further contributes a significant data stream connected to trials and post-market surveillance. The U.S. Food and Drug Administration (FDA) reports that the FDA Adverse Event Reporting System (FAERS) receives over 2 million adverse event reports annually in recent years, creating sustained demand for AI-driven case processing, duplicate detection, and signal detection to manage this scale efficiently.
Cloud-based deployment complements these analytics needs by providing flexible storage and computing resources for large datasets and AI model training. According to the U.S. National Institute of Standards and Technology (NIST), federal cloud guidance and standards—such as SP 800-145 and related cloud security publications updated between 2020 and 2024—have formalized baseline expectations for cloud usage and security, enabling broader adoption of cloud environments for regulated analytics workloads.
AI In Life Science Analytics Market- Geographical Insights
North America continues to be one of the most attractive regions for AI in life science analytics, thanks to its combination of high research funding, extensive clinical research activity, and well-established digital infrastructure for managing regulated health data. The U.S. National Institutes of Health (NIH) budget authority rose from $42.9 billion in FY2021 to $45.0 billion in FY2022, then to $47.5 billion in FY2023, and $48.6 billion in FY2024, supporting a vast amount of data-intensive biomedical research that requires automation and advanced analytics.
Clinical research activity further drives demand for AI analytics. According to ClinicalTrials.gov (U.S. National Library of Medicine), the registry surpassed 500,000 studies by 2024, reflecting the growing scale of trial-related datasets where AI is applied for feasibility analysis, patient identification, protocol monitoring, and reporting. Post-market and safety data add additional pressure on analytics workflows. The U.S. Food and Drug Administration (FDA) reports that the FDA Adverse Event Reporting System (FAERS) receives over 2 million adverse event reports annually in the 2020s, highlighting the need for AI-driven case processing, duplicate detection, and signal identification. Collectively, high research spending, expanding clinical trials, and large-scale safety data make North America a key market for AI adoption in life science analytics.
United States AI in Life Science Analytics Market- Country Insights
The United States is widely regarded as the single most significant market opportunity for AI in life science analytics due to consistently high government-backed research funding and large, regulated data streams. According to the NIH, budget authority reached $48.6 billion in FY2024, up from $45.0 billion in FY2022, supporting research networks that generate large-scale clinical and omics datasets. This robust research activity is mirrored in the scale of clinical trials; ClinicalTrials.gov reports that total registered studies surpassed 500,000 in 2024, fueling steady demand for AI-driven analytics in trial planning, operational oversight, and outcome evaluation.
Additionally, high volumes of safety reporting reinforce the need for AI solutions. The FDA’s Adverse Event Reporting System (FAERS) receives over 2 million reports annually in the 2020s, creating continuous demand for AI tools that can efficiently triage cases, detect patterns in unstructured text, and accelerate the identification of safety signals. Collectively, these factors make the U.S. a core market for AI adoption in life science analytics.
AI In Life Science Analytics Market- Competitive Landscape:
The competitive landscape of the AI in Life Science Analytics market is defined by the ability to manage regulated data at scale, integrate multiple life science datasets, and deploy AI models in production with audit-ready governance. Leading vendors excel in different capabilities: SAS is recognized for statistical analytics and compliance in regulated environments; IBM specializes in enterprise AI and NLP for unstructured text; Oracle provides robust life-science data systems and scalable cloud infrastructure; Microsoft delivers enterprise cloud and AI services with strong security controls; AWS offers elastic compute and data services for large-scale analytics; Google Cloud focuses on data engineering and AI/ML tools at scale; IQVIA leverages real-world data and commercial analytics; and Veeva leads in life-sciences workflows and commercial content/data management. Publicly reported indicators between 2020 and 2025—including rising NIH funding, increasing clinical trial registrations (ClinicalTrials.gov), and high annual safety-report inflows (FDA)—favor vendors capable of delivering compliant analytics, supporting high-volume pipelines, and integrating across clinical, safety, and R&D environments.
Recent Developments:
- December 2025: Medicus Pharma Ltd., a precision biotech/life sciences company, announced a non-binding LOI with Reliant AI Inc., a generative AI-focused life sciences firm, to develop an AI-powered analytics platform aimed at enhancing clinical trial execution. The platform will support dynamic site selection, patient stratification, and enrollment forecasting, initially focusing on an upcoming Teverelix clinical study planned for 2026.
- June 2025: IQVIA unveiled custom AI agents at GTC Paris, built using NVIDIA technology, to accelerate workflows and insights across target identification, clinical data review, literature review, market assessment, and HCP engagement. This follows a strategic collaboration begun in January to develop custom foundation models and agentic AI workflows for research, clinical development, and treatment access.
- February 2025: Medidata (Dassault Systèmes) outlined plans to expand AI and virtual-twin capabilities across clinical development. Generative experiences using synthetic data will simulate virtual patient cohorts to improve trial performance and reduce exposure to experimental therapies. Medidata currently supports 19 of the top 20 pharmaceutical companies, leveraging a large historical clinical trial dataset to enable patient-centric trial and post-trial outcome programs.
- June 2025: The U.S. FDA announced an expansion of its internal generative AI system, Elsa, in a secure GovCloud environment. Elsa aids staff in clinical protocol assessments, safety evaluations, and workflow efficiency while ensuring it does not train on regulated industry-submitted data to protect confidential information.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Accenture
- Amazon Web Services (AWS)
- Capgemini
- Cognizant
- Databricks
- Deloitte
- Google (Google Cloud)
- IBM
- Infosys
- IQVIA
- Microsoft
- NVIDIA
- Oracle
- Palantir Technologies
- SAP
- SAS
- Snowflake
- Tata Consultancy Services (TCS)
- Tempus
- Wipro
- Others
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032
- Software
- Services
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032
- Cloud-based
- On-premises
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Drug Discovery & Development
- Clinical Trials
- Sales & Marketing (Commercial Analytics)
- Supply Chain & Manufacturing
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Hospitals/Clinics & Research Institutes
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. AI In Life Science Analytics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. AI In Life Science Analytics Market Snippet by Offering
2.1.2. AI In Life Science Analytics Market Snippet by Deployment Mode
2.1.3. AI In Life Science Analytics Market Snippet by Application
2.1.4. AI In Life Science Analytics Market Snippet by End User
2.1.5. AI In Life Science Analytics Market Snippet by Country
2.1.6. AI In Life Science Analytics Market Snippet by Region
2.2. Competitive Insights
3. AI In Life Science Analytics Key Market Trends
3.1. AI In Life Science Analytics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. AI In Life Science Analytics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. AI In Life Science Analytics Market Opportunities
3.4. AI In Life Science Analytics Market Future Trends
4. AI In Life Science Analytics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. AI In Life Science Analytics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. AI In Life Science Analytics Market Landscape
6.1. AI In Life Science Analytics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. AI In Life Science Analytics Market – By Offering
7.1. Overview
7.1.1. Segment Share Analysis, By Offering, 2024 & 2032 (%)
7.1.2. Software
7.1.3. Services
8. AI In Life Science Analytics Market – By Deployment Mode
8.1. Overview
8.1.1. Segment Share Analysis, By Deployment Mode, 2024 & 2032 (%)
8.1.2. Cloud-based
8.1.3. On-premises
9. AI In Life Science Analytics Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Drug Discovery & Development
9.1.3. Clinical Trials
9.1.4. Sales & Marketing (Commercial Analytics)
9.1.5. Supply Chain & Manufacturing
10. AI In Life Science Analytics Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Deployment Mode, 2024 & 2032 (%)
10.1.2. Pharmaceutical Companies
10.1.3. Biotechnology Companies
10.1.4. Contract Research Organizations (CROs)
10.1.5. Hospitals/Clinics & Research Institutes
11. AI In Life Science Analytics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. AI In Life Science Analytics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. AI In Life Science Analytics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. AI In Life Science Analytics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. AI In Life Science Analytics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. AI In Life Science Analytics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- AI In Life Science Analytics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Accenture
12.2.2. Amazon Web Services (AWS)
12.2.3. Capgemini
12.2.4. Cognizant
12.2.5. Databricks
12.2.6. Deloitte
12.2.7. Google (Google Cloud)
12.2.8. IBM
12.2.9. Infosys
12.2.10. IQVIA
12.2.11. Microsoft
12.2.12. NVIDIA
12.2.13. Oracle
12.2.14. Palantir Technologies
12.2.15. SAP
12.2.16. SAS
12.2.17. Snowflake
12.2.18. Tata Consultancy Services (TCS)
12.2.19. Tempus
12.2.20. Wipro
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Accenture
- Amazon Web Services (AWS)
- Capgemini
- Cognizant
- Databricks
- Deloitte
- Google (Google Cloud)
- IBM
- Infosys
- IQVIA
- Microsoft
- NVIDIA
- Oracle
- Palantir Technologies
- SAP
- SAS
- Snowflake
- Tata Consultancy Services (TCS)
- Tempus
- Wipro
- Others
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032
- Software
- Services
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032
- Cloud-based
- On-premises
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Drug Discovery & Development
- Clinical Trials
- Sales & Marketing (Commercial Analytics)
- Supply Chain & Manufacturing
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Hospitals/Clinics & Research Institutes
GLOBAL AI IN LIFE SCIENCE ANALYTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
